Ron Bentsur - 24 Dec 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
24 Dec 2024
Net transactions value
+$20,925
Form type
4
Filing time
26 Dec 2024, 08:00:08 UTC
Previous filing
26 Nov 2024
Next filing
03 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $20,925 +4,500 +0.14% $4.65 3,270,924 24 Dec 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $4.64 to $4.67. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
F2 Includes 426,759 shares of restricted stock.